Latest Becker's muscular dystrophy Stories
-First drug for the underlying cause of nonsense mutation Duchenne muscular dystrophy - SOUTH PLAINFIELD, N.J., Dec. 3, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
COLUMBUS, Ohio, Nov. 17, 2014 /PRNewswire/ -- The International Duchenne Alliance announced today that it will allocate $500,000 to Jerry Mendell, M.D.
-Italian Medicines Agency (AIFA) approves cohort early access program - SOUTH PLAINFIELD, N.J., Nov. 3, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Data Supports Benefit in Nonsense Mutation Duchenne Muscular Dystrophy Patients SOUTH PLAINFIELD, N.J., Oct. 27, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
CLEVELAND and COLUMBUS, Ohio, Oct.
WACO, Texas, Sept.
However, Less Than One-Third of Duchenne Patients Are in Subpopulations That Will Benefit From New Disease-Modifying Therapies, According to Findings from Decision Resources Group BURLINGTON,
-Top-line data expected H2 2015- SOUTH PLAINFIELD, N.J., Sept. 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
-French ATU Cohort and Other Named Patient Programs Authorized - SOUTH PLAINFIELD, N.J., July 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc.
Parent Project Muscular Dystrophy-led guidance seeks to address unmet clinical needs of individuals with Duchenne muscular dystrophy and accelerate development of safe and effective therapies CHICAGO,
- a study of the individuals in a group of people within a specific context and their relationships.
- In rhetoric, the description of any one's personal appearance.